Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
WITHDRAWN
NA
INTERVENTIONAL
2009-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
The Study To Test The Effect of Standardization Of Fluid Intake In Female Patients With Overactive Bladder
NCT00553657
Comparison of Caffeine Reduction and Anticholinergic Medications for Treatment of Overactive Bladder
NCT00780832
Diversity in Patients With OAB
NCT05903105
Comparing Number of Injection Sites of In-office Intravesical Onabotulinumtoxin A Treatments for Overactive Bladder: A Randomized Controlled Trial
NCT05157295
Oxybutynin and Omega-3 for OAB (Overactive Bladder)
NCT02070042
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
SINGLE_GROUP
SUPPORTIVE_CARE
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
normal fluid intake
1500 ml /day (+/- 300 ml) for 2,5 days
water
drinking water / normal dietary fluids for oral intake
high fluid intake
2400 ml/day (+/- 300 ml )for 2,5 days
water
drinking water / normal dietary fluids for oral intake
low fluid intake
fluid intake 900 ml/day (+/- 300ml) for 2,5 days
water
drinking water / normal dietary fluids for oral intake
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
water
drinking water / normal dietary fluids for oral intake
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* neurogenic detrusor overactivity
* urine tract infection
* anticholinergics
* intravesical botulin toxin
* cardiac failure
* renal insufficiency
* sacral neurostimulation
* percutaneous neurostimulation
18 Years
75 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Radboud University Medical Center
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Heesakkers, dr. MD
Role: STUDY_CHAIR
dept of Urology, Radboud University Nijmegen Medical Centre
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Dept. of Urology, Radboud University Nijmegen Medical Centre
Nijmegen, Gelderland, Netherlands
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
OABdrinkstudy
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.